Clinical Trial Update: Combination of HMA and Venetoclax With Posaconazole in Patients With Acute Myeloid Leukemia: A Study of Plasma Concentrations

View source ↗

Summary

This completed trial reports pharmacokinetic data for a combination of a hypomethylating agent with venetoclax and posaconazole in adults with acute myeloid leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Hypomethylating agent
• POSACONAZOLE (POSACONAZOLE)
• Venetoclax (venetoclax)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: AML (Acute Myelogenous Leukemia | Status: COMPLETED